Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Director/PDMR Shareholding

24 Sep 2018 08:51

RNS Number : 6770B
Ricardo PLC
24 September 2018
 

Ricardo PLC

 

Director / PDMR Shareholdings

 

19 September 2018

London

 

Purchase of shares

 

Ricardo PLC (the "Company") announces that on 19 September 2018 it received notification that Mark Garrett, Chief Operating Officer, transferred a total of 59,206 ordinary shares of 25p each in the capital of the Company ("Shares") to his spouse, Melanie Garrett, on 18 September 2018, for nil consideration.

 

Following the above transfer, the total beneficial holding of Shares of Mark Garrett remains unchanged at 133,223 Shares, representing approximately 0.249% of the Company's issued ordinary share capital.

 

The following notification is intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Garrett

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ricardo plc

b)

LEI

213800ZNYAY35F4XB814

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 25p each ("Shares")

Identification code

GB0007370074

b)

Nature of the transaction

Transfer of Shares to Melanie Garrett, spouse of Mark Garrett

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil consideration

59,206

d)

Aggregated information

- Aggregated volume

- Price

Not applicable

e)

Date of the transaction

2018-09-18

f)

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMGZLNDVGRZG
Date   Source Headline
2nd Jan 20254:37 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSRicardo completes sale of Ricardo Defense
19th Dec 202411:49 amRNSHolding(s) in Company
18th Dec 202410:48 amRNSDirector/PDMR Shareholding
17th Dec 20243:40 pmRNSDirector/PDMR Shareholding
17th Dec 20243:39 pmRNSHolding(s) in Company
16th Dec 20247:01 amRNSRicardo to acquire E3 Advisory
16th Dec 20247:00 amRNSRicardo divests Ricardo Defense
11th Dec 20242:13 pmRNSHolding(s) in Company
2nd Dec 20245:01 pmRNSHolding(s) in Company
2nd Dec 202411:41 amRNSDirector/PDMR Shareholding
22nd Nov 20241:01 pmRNSDirector/PDMR Shareholding
22nd Nov 202412:51 pmRNSHolding(s) in Company
18th Nov 20243:31 pmRNSDirector/PDMR Shareholding
18th Nov 20242:02 pmRNSHolding(s) in Company - replacement
18th Nov 202412:46 pmRNSDirector/PDMR Shareholding
15th Nov 20244:20 pmRNSResult of AGM
30th Oct 202410:28 amRNSDirector/PDMR Shareholding
28th Oct 20245:29 pmRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSStrategy Update
17th Oct 20248:54 amRNSDirectorate Change
14th Oct 20242:12 pmRNSDirector/PDMR Shareholding
8th Oct 20245:39 pmRNSDirector/PDMR Shareholding
30th Sep 202411:15 amRNSTransaction in Own Shares
17th Sep 202411:04 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSPreliminary Results
3rd Sep 20247:00 amRNSNotice of Results and Investor Presentation
28th Aug 202412:00 pmRNSDirectorate Change
21st Aug 202410:52 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTrading Update
15th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 202410:50 amRNSDirectorate Change
12th Jun 20249:30 amRNSDirector/PDMR Shareholding
15th May 20243:20 pmRNSDirector/PDMR Shareholding
13th May 20249:25 amRNSDirector/PDMR Shareholding
3rd May 20247:43 amRNSDirectorate Change
30th Apr 20243:40 pmRNSDirector/PDMR Shareholding
22nd Apr 202411:14 amRNSDirector/PDMR Shareholding
22nd Apr 202411:08 amRNSHolding(s) in Company
11th Apr 20242:51 pmRNSDirector/PDMR Shareholding
3rd Apr 20241:48 pmRNSHolding(s) in Company
15th Mar 20245:30 pmRNSHolding(s) in Company
12th Mar 20245:30 pmRNSDirector/PDMR Shareholding
8th Mar 202410:30 amRNSInvestor Meet Company Webinar
7th Mar 20243:26 pmRNSDirector/PDMR Shareholding
7th Mar 202411:55 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSInterim Results
5th Mar 202410:04 amRNSDirectorate Change
13th Feb 20249:39 amRNSDirector/PDMR Shareholding
6th Feb 202410:14 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.